120 related articles for article (PubMed ID: 7004292)
1. Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings.
Thanik KD; Chey WY; Shah AN; Gutierrez JG
Ann Intern Med; 1980 Dec; 93(6):805-8. PubMed ID: 7004292
[TBL] [Abstract][Full Text] [Related]
2. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis.
Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT
Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158
[TBL] [Abstract][Full Text] [Related]
3. Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.
Thanik K; Chey WY; Shak A; Hamilton D; Nadelson N
Arch Intern Med; 1982 Aug; 142(8):1479-81. PubMed ID: 6125135
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.
Humphries TJ
J Clin Gastroenterol; 1987 Feb; 9(1):28-32. PubMed ID: 2881958
[TBL] [Abstract][Full Text] [Related]
5. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
Petrokubi RJ; Jeffries GH
Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
[TBL] [Abstract][Full Text] [Related]
6. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
[TBL] [Abstract][Full Text] [Related]
7. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study.
Carling L; Cronstedt J; Engqvist A; Kagevi I; Nyström B; Svedberg LE; Thorhallsson E; Unge P; Wingren PE
Scand J Gastroenterol; 1988 Nov; 23(9):1117-24. PubMed ID: 3073524
[TBL] [Abstract][Full Text] [Related]
8. Oral cimetidine in reflux esophagitis: a double blind controlled trial.
Wesdorp E; Bartelsman J; Pape K; Dekker W; Tytgat GN
Gastroenterology; 1978 May; 74(5 Pt 1):821-4. PubMed ID: 346430
[TBL] [Abstract][Full Text] [Related]
9. [Gastroesophageal reflux disease and reflux esophagitis. Therapeutic modifiability by bethanechol chloride].
Hunold W
ZFA (Stuttgart); 1982 Oct; 58(29):1623-8. PubMed ID: 6129755
[No Abstract] [Full Text] [Related]
10. Medical management of reflux esophagitis.
Vantrappen G; Janssens J
Digestion; 1985; 32 Suppl 1():51-8. PubMed ID: 2866136
[TBL] [Abstract][Full Text] [Related]
11. [Cimetidine treatment of reflux esophagitis: results of a double-blind study].
Sonnenberg A; Lepsien G; Berges W; Weber KB; Wienbeck M; Siewert JR; Blum AL
Schweiz Med Wochenschr; 1979 Apr; 109(16):613-5. PubMed ID: 373103
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe reflux esophagitis with cimetidine and metoclopramide.
Lieberman DA; Keeffe EB
Ann Intern Med; 1986 Jan; 104(1):21-6. PubMed ID: 3940501
[TBL] [Abstract][Full Text] [Related]
13. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
Breen KJ; Desmond PV; Whelan G
Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.
Reed PI; Davies WA
Am J Dig Dis; 1978 Feb; 23(2):161-5. PubMed ID: 341689
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials.
Tytgat GN; Nicolai JJ; Reman FC
Gastroenterology; 1990 Sep; 99(3):629-34. PubMed ID: 2199289
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in the pathogenesis and treatment of reflux esophagitis.
Frazier JL; Fendler KJ
Clin Pharm; 1983; 2(6):546-57. PubMed ID: 6360495
[TBL] [Abstract][Full Text] [Related]
17. Treatment of reflux oesophagitis with ranitidine.
Wesdorp IC; Dekker W; Klinkenberg-Knol EC
Gut; 1983 Oct; 24(10):921-4. PubMed ID: 6311693
[TBL] [Abstract][Full Text] [Related]
18. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis.
Scobie BA
Med J Aust; 1976 Apr; 1(17):627-8. PubMed ID: 778564
[TBL] [Abstract][Full Text] [Related]
19. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy for reflux esophagitis: 1986 and beyond.
Castell DO
Ann Intern Med; 1986 Jan; 104(1):112-4. PubMed ID: 2866742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
